Neurofeedback is among the most exciting technological advances in medicine. Studies are emerging that confirm what practitioners have witnessed for years.
In 2012, the American Academy of Pediatrics underwent a rigorous review of all the available data on neurofeedback. The following policy statement was developed from this review process:
The American Academy of Pediatrics approved biofeedback and neurofeedback as aLevel 1 or “best support” treatment option for children suffering from ADHD.
Research and clinical studies show many cognitive issues which are unresponsive to medication or psychotherapy often can be resolved within 20-40 Neurofeedback therapy sessions. Others require a greater number of sessions. Chronic, longstanding emotional and physical issues, including those complicated by substance abuse, can show marked improvement within 20 treatments.
2009 Clinical Study for Neurofeedback and ADHD
(click above title to view the original study)
In 2009 one of the best clinical trials so far on the effectiveness of Neurofeedback on ADHD was published. In this trial researchers studied 102 children with ADHD, age 8-12 years, for 36 sessions of Neurofeedback and compared it to 36 sessions of computerized attention skills training as a the control. Researchers carefully rated progress using pre-training, intermediate and post-training assessments completed by parents and teachers. In their findings, researchers found that Neurofeedback was more effective than the control group doing only attention skills training and thus established clinical efficacy for Neurofeedback that was statistically significant.